NuView takes control of Texas radioisotope production facility
NuView Life Sciences has agreed to assume management of Trace Life Sciences, including operations of the linear accelerator and cyclotron production facilities in Denton, Texas.
The Trace facility produces Copper-64, Copper- 67, Indium-111, Iodine-123 and Thallium-201 used in molecular imaging and nuclear medicine.
NuView's Chief Medical Officer Peter Conti, MD, PhD, said that the company anticipates the ability to produce novel radioisotopes to satisfy unmet needs of the research community.
The Park City, Utah-based life-sciences company said it is focused on identifying and developing emerging novel diagnostic or targeted therapies.
The Trace facility produces Copper-64, Copper- 67, Indium-111, Iodine-123 and Thallium-201 used in molecular imaging and nuclear medicine.
NuView's Chief Medical Officer Peter Conti, MD, PhD, said that the company anticipates the ability to produce novel radioisotopes to satisfy unmet needs of the research community.
The Park City, Utah-based life-sciences company said it is focused on identifying and developing emerging novel diagnostic or targeted therapies.